Effect of semaglutide 2.4 mg once weekly on 10‐year type 2 diabetes risk in adults with overweight or obesity
L Wilkinson, T Holst‐Hansen, PN Laursen, AR Rinnov… - …, 2023 - Wiley Online Library
Abstract Objective In the Semaglutide Treatment Effect in People with obesity (STEP) trials,
once‐weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention reduced body …
once‐weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention reduced body …
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity.
L Wilkinson, T Holst-Hansen, PN Laursen… - Obesity (Silver Spring …, 2023 - europepmc.org
Objective In the Semaglutide Treatment Effect in People with obesity (STEP) trials, once-
weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention reduced body weight …
weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention reduced body weight …
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity
L Wilkinson, T Holst-Hansen… - … (Silver Spring, Md …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective In the Semaglutide Treatment Effect in People with obesity (STEP) trials, once-
weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention reduced body weight …
weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention reduced body weight …